AstraZeneca, Targacept drug fails depression testLONDON (Reuters) - An experimental antidepressant fromAstraZeneca Plc and Targacept Inc failed to meet the goal of changing a key depression rating score in the first of a series ofpivotal clinical trials, in a setback for both firms. Nov 08, 2011